Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 245

1.

Relationship between glycated hemoglobin level and duration of hypoglycemia in type 2 diabetes patients treated with sulfonylureas: A multicenter cross-sectional study.

Matsuoka A, Hirota Y, Takeda A, Kishi M, Hashimoto N, Ohara T, Higo S, Yamada H, Nakamura T, Hamaguchi T, Takeuchi T, Nakagawa Y, Okada Y, Sakaguchi K, Ogawa W.

J Diabetes Investig. 2019 Aug 28. doi: 10.1111/jdi.13132. [Epub ahead of print]

2.

Association of body fat mass with left ventricular longitudinal myocardial systolic function in type 2 diabetes mellitus.

Hatani Y, Tanaka H, Mochizuki Y, Suto M, Yokota S, Mukai J, Takada H, Soga F, Hatazawa K, Matsuzoe H, Matsumoto K, Hirota Y, Ogawa W, Hirata KI.

J Cardiol. 2019 Aug 23. pii: S0914-5087(19)30239-4. doi: 10.1016/j.jjcc.2019.07.013. [Epub ahead of print]

PMID:
31451315
3.

Repeated fruiting of Japanese golden chanterelle in pot culture with host seedlings.

Ogawa W, Takeda Y, Endo N, Yamashita S, Takayama T, Fukuda M, Yamada A.

Mycorrhiza. 2019 Jul 24. doi: 10.1007/s00572-019-00908-z. [Epub ahead of print]

PMID:
31342139
4.

The Novel Lipid-Lowering Drug D-47 Ameliorates Hepatic Steatosis and Promotes Brown/Beige-Like Change of White Adipose Tissue in db/db Mice.

Mizusaki N, Nomura K, Hosooka T, Shiomi M, Ogawa K, Tsunoda T, Tamori Y, Ogawa W.

Kobe J Med Sci. 2019 Jun 17;65(1):E36-E43.

5.

Acromegaly caused by a somatotroph adenoma in patient with neurofibromatosis type 1.

Hozumi K, Fukuoka H, Odake Y, Takeuchi T, Uehara T, Sato T, Inoshita N, Yoshida K, Matsumoto R, Bando H, Hirota Y, Iguchi G, Taniguchi M, Otsuki N, Nishigori C, Kosaki K, Hasegawa T, Ogawa W, Takahashi Y.

Endocr J. 2019 Jun 12. doi: 10.1507/endocrj.EJ19-0035. [Epub ahead of print]

6.

Efficacy of preoperative amino acid supplements on postoperative physical function and complications in open heart surgery patients: A study protocol for a randomized controlled trial.

Ogawa M, Yoshida N, Satomi-Kobayashi S, Tsuboi Y, Komaki K, Wakida K, Gotake Y, Inoue T, Tanaka H, Yamashita T, Sakai Y, Izawa KP, Takahashi M, Ogawa W, Hirata KI.

J Cardiol. 2019 Oct;74(4):360-365. doi: 10.1016/j.jjcc.2019.03.011. Epub 2019 Apr 15.

PMID:
31000320
7.

Relationship Between Number of Multiple Risk Factors and Coronary Artery Disease Risk With and Without Diabetes Mellitus.

Yamada-Harada M, Fujihara K, Osawa T, Yamamoto M, Kaneko M, Kitazawa M, Matsubayashi Y, Yamada T, Yamanaka N, Seida H, Ogawa W, Sone H.

J Clin Endocrinol Metab. 2019 Nov 1;104(11):5084-5090. doi: 10.1210/jc.2019-00168.

PMID:
30994885
8.

Glucagon secretions are impaired in patients with fulminant type 1 diabetes.

Komada H, Hirota Y, Ogawa W.

J Diabetes Investig. 2019 May;10(3):866-867. doi: 10.1111/jdi.13041. Epub 2019 Apr 11.

9.

Fat-specific protein 27α inhibits autophagy-dependent lipid droplet breakdown in white adipocytes.

Nakajima S, Nishimoto Y, Tateya S, Iwahashi Y, Okamatsu-Ogura Y, Saito M, Ogawa W, Tamori Y.

J Diabetes Investig. 2019 Mar 30. doi: 10.1111/jdi.13050. [Epub ahead of print]

10.

Comprehensive analysis of resistance-nodulation-cell division superfamily (RND) efflux pumps from Serratia marcescens, Db10.

Toba S, Minato Y, Kondo Y, Hoshikawa K, Minagawa S, Komaki S, Kumagai T, Matoba Y, Morita D, Ogawa W, Gotoh N, Tsuchiya T, Kuroda T.

Sci Rep. 2019 Mar 19;9(1):4854. doi: 10.1038/s41598-019-41237-7.

11.

Hyperglycemia induces skeletal muscle atrophy via a WWP1/KLF15 axis.

Hirata Y, Nomura K, Senga Y, Okada Y, Kobayashi K, Okamoto S, Minokoshi Y, Imamura M, Takeda S, Hosooka T, Ogawa W.

JCI Insight. 2019 Feb 21;4(4). pii: 124952. doi: 10.1172/jci.insight.124952. eCollection 2019 Feb 21.

12.

Usefulness of hemoglobin A1c and glycated albumin measurements for insulinoma screening: an observational case-control study.

Torimoto K, Okada Y, Tanaka Y, Matsuoka A, Hirota Y, Ogawa W, Saisho Y, Kurihara I, Itoh H, Inada S, Koga M.

BMC Cancer. 2019 Feb 26;19(1):174. doi: 10.1186/s12885-019-5389-7.

13.

SGLT2 inhibitors and protection against pancreatic beta cell failure.

Asahara SI, Ogawa W.

Diabetol Int. 2018 Sep 17;10(1):1-2. doi: 10.1007/s13340-018-0374-y. eCollection 2019 Jan. No abstract available.

14.
15.

Effects of ipragliflozin on glycemic control, appetite and its related hormones: A prospective, multicenter, open-label study (SOAR-KOBE Study).

Miura H, Sakaguchi K, Okada Y, Yamada T, Otowa-Suematsu N, So A, Komada H, Hirota Y, Ohara T, Kuroki Y, Hara K, Matsuda T, Kishi M, Takeda A, Yokota K, Tamori Y, Ogawa W.

J Diabetes Investig. 2019 Sep;10(5):1254-1261. doi: 10.1111/jdi.13015. Epub 2019 Mar 28.

16.

Phenotypic differences and similarities of monozygotic twins with maturity-onset diabetes of the young type 5.

Ohara Y, Okada Y, Yamada T, Sugawara K, Kanatani M, Fukuoka H, Hirota Y, Maeda T, Morisada N, Iijima K, Ogawa W.

J Diabetes Investig. 2019 Jul;10(4):1112-1115. doi: 10.1111/jdi.13004. Epub 2019 Feb 15.

17.

IgG4-related hypophysitis in patients with autoimmune pancreatitis.

Kanie K, Bando H, Iguchi G, Shiomi H, Masuda A, Fukuoka H, Nishizawa H, Fujita Y, Sakai A, Kobayashi T, Shiomi Y, Yoshida K, Matsumoto R, Suda K, Kodama Y, Ogawa W, Takahashi Y.

Pituitary. 2019 Feb;22(1):54-61. doi: 10.1007/s11102-018-00930-y.

PMID:
30607745
18.

Effect of switching from conventional continuous subcutaneous insulin infusion to sensor augmented pump therapy on glycemic profile in Japanese patients with type 1 diabetes.

Matsuoka A, Hirota Y, Urai S, Hamaguchi T, Takeuchi T, Miura H, Suematsu N, So A, Nakamura T, Komada H, Okada Y, Sakaguchi K, Ogawa W.

Diabetol Int. 2018 Jan 22;9(3):201-207. doi: 10.1007/s13340-018-0344-4. eCollection 2018 Jul.

19.

Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis.

Yoshida N, Emoto T, Yamashita T, Watanabe H, Hayashi T, Tabata T, Hoshi N, Hatano N, Ozawa G, Sasaki N, Mizoguchi T, Amin HZ, Hirota Y, Ogawa W, Yamada T, Hirata KI.

Circulation. 2018 Nov 27;138(22):2486-2498. doi: 10.1161/CIRCULATIONAHA.118.033714.

PMID:
30571343
20.

Effect of awards after dental care in children's motivation.

Rank RCIC, Vilela JER, Rank MS, Ogawa WN, Imparato JCP.

Eur Arch Paediatr Dent. 2019 Apr;20(2):85-93. doi: 10.1007/s40368-018-0394-0. Epub 2018 Dec 18.

PMID:
30560523
21.

Gut Microbiome and Plasma Microbiome-Related Metabolites in Patients With Decompensated and Compensated Heart Failure.

Hayashi T, Yamashita T, Watanabe H, Kami K, Yoshida N, Tabata T, Emoto T, Sasaki N, Mizoguchi T, Irino Y, Toh R, Shinohara M, Okada Y, Ogawa W, Yamada T, Hirata KI.

Circ J. 2018 Dec 25;83(1):182-192. doi: 10.1253/circj.CJ-18-0468. Epub 2018 Nov 29.

22.

Effects of exenatide and liraglutide on postchallenge glucose disposal in individuals with normal glucose tolerance.

Hirota Y, Matsuda T, Nakajima S, Takabe M, Hashimoto N, Nakamura T, Okada Y, Sakaguchi K, Ogawa W.

Endocrine. 2019 Apr;64(1):43-47. doi: 10.1007/s12020-018-1808-9. Epub 2018 Nov 8.

PMID:
30406884
23.

Docosahexaenoic Acid Reduces Palmitic Acid-Induced Endoplasmic Reticulum Stress in Pancreatic Β Cells.

Suzuki E, Matsuda T, Kawamoto T, Takahashi H, Mieda Y, Matsuura Y, Takai T, Kanno A, Koyanagi-Kimura M, Asahara SI, Inoue H, Ogawa W, Kido Y.

Kobe J Med Sci. 2018 Sep 11;64(2):E43-E55.

24.

The prescription rates of glucagon for hypoglycemia by pediatricians and physicians are low in Japan.

Matsumoto M, Awano H, Hirota Y, Nagai M, Bo R, Matsuoka A, Hamaguchi T, Takeuchi T, Nakagawa Y, Ogawa W, Iijima K.

Endocrine. 2019 May;64(2):233-238. doi: 10.1007/s12020-018-1793-z. Epub 2018 Oct 26.

PMID:
30367442
25.

Effects of Insulin Degludec and Insulin Glargine U300 on Day-to-Day Fasting Plasma Glucose Variability in Individuals with Type 1 Diabetes: A Multicenter, Randomized, Crossover Study (Kobe Best Basal Insulin Study 2).

Miura H, Sakaguchi K, Okada Y, Otowa-Suematsu N, Yamada T, So A, Komada H, Hirota Y, Kishi M, Takeda A, Tominaga Y, Nakamura T, Kuroki Y, Matsuda T, Iida K, Kajikawa M, Ohara T, Yokota K, Hara K, Tateya S, Tamori Y, Ogawa W.

Diabetes Ther. 2018 Dec;9(6):2399-2406. doi: 10.1007/s13300-018-0523-0. Epub 2018 Oct 19.

26.

In silico and in vitro analyses of the pathological relevance of the R258H mutation of hepatocyte nuclear factor 4α identified in maturity-onset diabetes of the young type 1.

Sugawara K, Nomura K, Okada Y, Sugano A, Matsumoto M, Takarada T, Takeuchi A, Awano H, Hirota Y, Nishio H, Takaoka Y, Ogawa W.

J Diabetes Investig. 2019 May;10(3):680-684. doi: 10.1111/jdi.12960. Epub 2018 Dec 10.

27.

Early administration of dapagliflozin preserves pancreatic β-cell mass through a legacy effect in a mouse model of type 2 diabetes.

Kanno A, Asahara SI, Kawamura M, Furubayashi A, Tsuchiya S, Suzuki E, Takai T, Koyanagi-Kimura M, Matsuda T, Okada Y, Ogawa W, Kido Y.

J Diabetes Investig. 2019 May;10(3):577-590. doi: 10.1111/jdi.12945. Epub 2018 Nov 8.

28.

Modulation of lipid mediator profile may contribute to amelioration of chronic inflammation in adipose tissue of obese mice by pioglitazone.

Okada K, Hosooka T, Shinohara M, Ogawa W.

Biochem Biophys Res Commun. 2018 Oct 20;505(1):29-35. doi: 10.1016/j.bbrc.2018.09.081. Epub 2018 Sep 17.

PMID:
30236987
29.

Association of treatment-achieved HbA1c with incidence of coronary artery disease and severe eye disease in diabetes patients.

Harada M, Fujihara K, Osawa T, Yamamoto M, Kaneko M, Ishizawa M, Matsubayashi Y, Yamada T, Yamanaka N, Seida H, Kodama S, Ogawa W, Sone H.

Diabetes Metab. 2018 Sep 10. pii: S1262-3636(18)30167-8. doi: 10.1016/j.diabet.2018.08.009. [Epub ahead of print]

PMID:
30213710
30.

Comprehensive Evaluation of Combination Therapy with Basal Insulin and Either Lixisenatide or Vildagliptin in Japanese Patients with Type 2 Diabetes: A Randomized, Open-Label, Parallel-Group, Multicenter Study.

Otowa-Suematsu N, Sakaguchi K, Nakamura T, Hara K, Kishi M, Hashimoto N, Yokota K, Yoshino H, Kuroki Y, Nishiumi T, Sou A, Komada H, Okada Y, Hirota Y, Tamori Y, Ogawa W.

Diabetes Ther. 2018 Oct;9(5):2067-2079. doi: 10.1007/s13300-018-0505-2. Epub 2018 Sep 11.

31.

Impaired glucagon secretion in patients with fulminant type 1 diabetes mellitus.

Komada H, Hirota Y, Sakaguchi K, Okuno Y, Ogawa W, Seino S.

Endocrine. 2019 Mar;63(3):476-479. doi: 10.1007/s12020-018-1750-x. Epub 2018 Sep 10.

PMID:
30203124
32.

Isolated adrenocorticotropic hormone deficiency as a form of paraneoplastic syndrome.

Bando H, Iguchi G, Kanie K, Nishizawa H, Matsumoto R, Fujita Y, Odake Y, Yoshida K, Suda K, Fukuoka H, Tanaka K, Ogawa W, Takahashi Y.

Pituitary. 2018 Oct;21(5):480-489. doi: 10.1007/s11102-018-0901-7.

PMID:
30008158
33.

Central insulin action induces activation of paraventricular oxytocin neurons to release oxytocin into circulation.

Zhang B, Nakata M, Nakae J, Ogawa W, Yada T.

Sci Rep. 2018 Jul 10;8(1):10415. doi: 10.1038/s41598-018-28816-w.

34.

Data on impact of monocytes and glucose fluctuation on plaque vulnerability in patients with coronary artery disease.

Yamamoto H, Yoshida N, Shinke T, Otake H, Kuroda M, Sakaguchi K, Hirota Y, Toba T, Takahashi H, Terashita D, Uzu K, Tahara N, Shinkura Y, Kuroda K, Nagasawa Y, Nagano Y, Tsukiyama Y, Yanaka KI, Emoto T, Sasaki N, Yamashita T, Ogawa W, Hirata KI.

Data Brief. 2018 Mar 10;18:172-175. doi: 10.1016/j.dib.2018.03.022. eCollection 2018 Jun.

35.

Mechanisms of metformin action: In and out of the gut.

Minamii T, Nogami M, Ogawa W.

J Diabetes Investig. 2018 Jul;9(4):701-703. doi: 10.1111/jdi.12864. Epub 2018 Jun 5.

36.

Protective role of AgRP neuron's PDK1 against salt-induced hypertension.

Zhang B, Nakata M, Lu M, Nakae J, Okada T, Ogawa W, Yada T.

Biochem Biophys Res Commun. 2018 Jun 12;500(4):910-916. doi: 10.1016/j.bbrc.2018.04.192. Epub 2018 Apr 30.

PMID:
29705701
37.

Increase in hepatic and decrease in peripheral insulin clearance characterize abnormal temporal patterns of serum insulin in diabetic subjects.

Ohashi K, Fujii M, Uda S, Kubota H, Komada H, Sakaguchi K, Ogawa W, Kuroda S.

NPJ Syst Biol Appl. 2018 Mar 14;4:14. doi: 10.1038/s41540-018-0051-6. eCollection 2018.

38.

Treatment of a case of severe insulin resistance as a result of a PIK3R1 mutation with a sodium-glucose cotransporter 2 inhibitor.

Hamaguchi T, Hirota Y, Takeuchi T, Nakagawa Y, Matsuoka A, Matsumoto M, Awano H, Iijima K, Cha PC, Satake W, Toda T, Ogawa W.

J Diabetes Investig. 2018 Sep;9(5):1224-1227. doi: 10.1111/jdi.12825. Epub 2018 Mar 25.

39.

Casein kinase 2 phosphorylates and stabilizes C/EBPβ in pancreatic β cells.

Takai T, Matsuda T, Matsuura Y, Inoue K, Suzuki E, Kanno A, Kimura-Koyanagi M, Asahara SI, Hatano N, Ogawa W, Kido Y.

Biochem Biophys Res Commun. 2018 Feb 26;497(1):451-456. doi: 10.1016/j.bbrc.2018.02.108. Epub 2018 Feb 12.

PMID:
29448105
40.

Impact of CD14++CD16+ monocytes on coronary plaque vulnerability assessed by optical coherence tomography in coronary artery disease patients.

Yamamoto H, Yoshida N, Shinke T, Otake H, Kuroda M, Sakaguchi K, Hirota Y, Toba T, Takahashi H, Terashita D, Uzu K, Tahara N, Shinkura Y, Kuroda K, Nagasawa Y, Nagano Y, Tsukiyama Y, Yanaka KI, Emoto T, Sasaki N, Yamashita T, Ogawa W, Hirata KI.

Atherosclerosis. 2018 Feb;269:245-251. doi: 10.1016/j.atherosclerosis.2018.01.010. Epub 2018 Jan 17.

PMID:
29407600
41.

Factors correlated with serum insulin-like growth factor-I levels in health check-up subjects.

Matsumoto R, Koga M, Kasayama S, Fukuoka H, Iguchi G, Odake Y, Yoshida K, Bando H, Suda K, Nishizawa H, Takahashi M, Ogawa W, Takahashi Y.

Growth Horm IGF Res. 2018 Jun;40:55-60. doi: 10.1016/j.ghir.2018.01.003. Epub 2018 Jan 31.

PMID:
29395967
42.

Multiple Salivary Cortisol Measurements Are a Useful Tool to Optimize Metyrapone Treatment in Patients with Cushing's Syndromes Treatment: Case Presentations.

Yoshida K, Fukuoka H, Odake Y, Nakajima S, Tachibana M, Ito J, Hosokawa Y, Yamada T, Miura H, Suematsu N, Matsumoto R, Bando H, Suda K, Nishizawa H, Iguchi G, Ogawa W, Takahashi Y.

Front Endocrinol (Lausanne). 2018 Jan 11;8:375. doi: 10.3389/fendo.2017.00375. eCollection 2017.

43.

Two Cases of Atezolizumab-Induced Hypophysitis.

Kanie K, Iguchi G, Bando H, Fujita Y, Odake Y, Yoshida K, Matsumoto R, Fukuoka H, Ogawa W, Takahashi Y.

J Endocr Soc. 2017 Dec 13;2(1):91-95. doi: 10.1210/js.2017-00414. eCollection 2018 Jan 1.

44.

Impact of overweight on left ventricular function in type 2 diabetes mellitus.

Suto M, Tanaka H, Mochizuki Y, Mukai J, Takada H, Soga F, Dokuni K, Hatani Y, Hatazawa K, Matsuzoe H, Sano H, Shimoura H, Ooka J, Matsumoto K, Hirota Y, Ogawa W, Hirata KI.

Cardiovasc Diabetol. 2017 Nov 9;16(1):145. doi: 10.1186/s12933-017-0632-5.

45.

Efficacy of a public promotion program on children's oral health.

Alves APS, Rank RCIC, Vilela JER, Rank MS, Ogawa WN, Molina OF.

J Pediatr (Rio J). 2018 Sep - Oct;94(5):518-524. doi: 10.1016/j.jped.2017.07.012. Epub 2017 Sep 25.

46.

Comparison of the relationship between multiple parameters of glycemic variability and coronary plaque vulnerability assessed by virtual histology-intravascular ultrasound.

Otowa-Suematsu N, Sakaguchi K, Komada H, Nakamura T, Sou A, Hirota Y, Kuroda M, Shinke T, Hirata KI, Ogawa W.

J Diabetes Investig. 2017 Sep 16. doi: 10.1111/jdi.12750. [Epub ahead of print]

47.

Impact of CD14++CD16+ monocytes on plaque vulnerability in diabetic and non-diabetic patients with asymptomatic coronary artery disease: a cross-sectional study.

Yoshida N, Yamamoto H, Shinke T, Otake H, Kuroda M, Terashita D, Takahashi H, Sakaguchi K, Hirota Y, Emoto T, Amin HZ, Mizoguchi T, Hayashi T, Sasaki N, Yamashita T, Ogawa W, Hirata KI.

Cardiovasc Diabetol. 2017 Aug 8;16(1):96. doi: 10.1186/s12933-017-0577-8.

48.

Pancreatic fat content assessed by 1 H magnetic resonance spectroscopy is correlated with insulin resistance, but not with insulin secretion, in Japanese individuals with normal glucose tolerance.

Komada H, Sakaguchi K, Hirota Y, Sou A, Nakamura T, Kyotani K, Kawamitsu H, Sugimura K, Okuno Y, Ogawa W.

J Diabetes Investig. 2017 Aug 2. doi: 10.1111/jdi.12720. [Epub ahead of print]

49.

Insulin Secretion and Insulin Sensitivity Before and After Surgical Treatment of Pheochromocytoma or Paraganglioma.

Komada H, Hirota Y, So A, Nakamura T, Okuno Y, Fukuoka H, Iguchi G, Takahashi Y, Sakaguchi K, Ogawa W.

J Clin Endocrinol Metab. 2017 Sep 1;102(9):3400-3405. doi: 10.1210/jc.2017-00357.

PMID:
28666346
50.

Impact of left ventricular longitudinal functional mechanics on the progression of diastolic function in diabetes mellitus.

Mochizuki Y, Tanaka H, Matsumoto K, Sano H, Shimoura H, Ooka J, Sawa T, Motoji Y, Ryo-Koriyama K, Hirota Y, Ogawa W, Hirata KI.

Int J Cardiovasc Imaging. 2017 Dec;33(12):1905-1914. doi: 10.1007/s10554-017-1198-8. Epub 2017 Jun 22.

PMID:
28642993

Supplemental Content

Support Center